Johns Hopkins University, U.S.
New findings in breast cancer described from the United States and Canada
Published in Medicine and Law Weekly, July 7th, 2006
Study 1: Lower breast cancer progression from benign breast disease may be linked to aspirin use.
"Biopsy-proven benign breast disease (BBD) is a risk factor for developing breast carcinoma; however, to the authors' knowledge, little is known regarding factors related to progression to carcinoma. A cohort study was conducted to examine the role of cyclooxygenase (COX) polymorphisms and nonsteroidal anti-inflammatory drugs (NSAIDs) in the progression of BBD to breast carcinoma," scientists at Johns Hopkins University reported.
L. Gallicchio and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Accu-Break Pharmaceuticals
Accu-Break, Strides Arcolab enter joint venture to develop generic pharmaceuticals - Alnylam Pharmaceuticals
Alnylam issued U.S. patent broadly covering RNAi therapeutics - Awards
Humana wins Stevie Award for best new product - Baylor College of Medicine, U.S.
Ethics for clinical trials enrollment for women of childbearing potential emphasized - Biophan Technologies
Biophan is issued U.S. patents related to cardiac pacing - Bradmer Pharmaceuticals
Bradmer extends patent portfolio with allowance letter from European Patent Office - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
